The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells

被引:286
作者
Du, JB [1 ]
Hui, Y
Cheung, YF
Bin, G
Jiang, HF
Chen, XB
Tang, CS
机构
[1] Peking Univ, Hosp 1, Dept Pediat, Xi An Men Str 1,W Dist, Beijing 100034, Peoples R China
[2] Univ Hong Kong, Grantham Hosp, Dept Pediat Cardiol, Hong Kong, Hong Kong, Peoples R China
[3] Peking Univ, Hosp 1, Inst Cardiovasc Dis, Beijing 100871, Peoples R China
基金
美国国家卫生研究院;
关键词
hydrogen sulfide; endothelin; aorta; mitogen-activated protein kinase; gasotransmitter;
D O I
10.1007/s00380-003-0743-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hydrogen sulfide (H2S) was recently suggested to be a possible endogenous gasotransmitter in physiological concentration. For the purpose of understanding its possible role in the regulation of the cardiovascular system, we explored the potential effect of H2S on the proliferation of cultured aortic vascular smooth muscle cells (VSMCs) of rats and mitrogen-activated protein kinase (MAPK) as a signaling transduction pathway. Vascular smooth muscle cells were cultured in vitro and the cells were divided into six groups: (1) control group, (2) serum group, (3) endothelin group, (4) NaHS group, (5) serum + NaHS group, and (6) endothelin + NaHS group. VSMC proliferation was measured by [H-3]thymidine ([H-3]TdR) incorporation and MAPK activity in the VSMCs was determined by radioactivity assay. The results showed that endothelin-1 increased VSMC [H-3]TdR incorporation 2.39-fold (P<0.01) and MAPK activity 1.62-fold (P<0.01), as compared with controls. Hydrogen sulfide at 5x10(-5) mol/l, 1x10(-4) mol/l, and 5x10(-4) mol/l decreased VSMC [H-3]TdR incorporation by 16.8%, 26.60%, and 37.40%, respectively, and reduced MAPK activity by 7.37% (P>0.05), 23.39%, and 33.57%, respectively (P<0.01). The results demonstrated that H,S could dose-dependently suppress the proliferation of VSMCs through the MAPK pathway.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 18 条
  • [1] Abe K, 1996, J NEUROSCI, V16, P1066
  • [2] BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110
  • [3] NITRIC OXIDE-GENERATING VASODILATORS AND 8-BROMO-CYCLIC GUANOSINE-MONOPHOSPHATE INHIBIT MITOGENESIS AND PROLIFERATION OF CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS
    GARG, UC
    HASSID, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) : 1774 - 1777
  • [4] Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension
    Hampl, V
    Herget, J
    [J]. PHYSIOLOGICAL REVIEWS, 2000, 80 (04) : 1337 - 1372
  • [5] CALCITONIN GENE-RELATED PEPTIDE RECEPTOR IN CULTURED VASCULAR SMOOTH-MUSCLE AND ENDOTHELIAL-CELLS
    HIRATA, Y
    TAKAGI, Y
    TAKATA, S
    FUKUDA, Y
    YOSHIMI, H
    FUJITA, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (03) : 1113 - 1121
  • [6] The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide
    Hosoki, R
    Matsuki, N
    Kimura, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 527 - 531
  • [7] Effect of homocysteine on the L-arginine/nitric oxide synthase/nitric oxide pathway in human platelets
    Li, JX
    Zhang, YG
    Yao, XH
    Zhang, BW
    Du, JB
    Tang, CS
    [J]. HEART AND VESSELS, 2002, 16 (02) : 46 - 50
  • [8] LI TC, 1999, BAS MED SCI CLIN, V16, P158
  • [9] Nitric oxide plays an insignificant role in direct vasodilator effects of calcium channel blockers in healthy humans
    Nakamura, M
    Arakawa, N
    Yoshida, H
    Naganuma, Y
    Nagano, M
    Hiramori, K
    [J]. HEART AND VESSELS, 2002, 16 (03) : 105 - 110
  • [10] NITRIC-OXIDE RELEASE ACCOUNTS FOR THE BIOLOGICAL-ACTIVITY OF ENDOTHELIUM-DERIVED RELAXING FACTOR
    PALMER, RMJ
    FERRIGE, AG
    MONCADA, S
    [J]. NATURE, 1987, 327 (6122) : 524 - 526